Your browser doesn't support javascript.
loading
The F2-isoprostane 8-iso-PGF attenuates atherosclerotic lesion formation in Ldlr-deficient mice - Potential role of vascular thromboxane A2 receptors.
Braun, Heike; Hauke, Michael; Eckenstaler, Robert; Petermann, Markus; Ripperger, Anne; Kühn, Niklas; Schwedhelm, Edzard; Ludwig-Kraus, Beatrice; Kraus, Frank Bernhard; Dubourg, Virginie; Zernecke, Alma; Schreier, Barbara; Gekle, Michael; Benndorf, Ralf A.
Afiliação
  • Braun H; Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Hauke M; Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Eckenstaler R; Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Petermann M; Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Ripperger A; Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Kühn N; Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Schwedhelm E; Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ludwig-Kraus B; Central Laboratory, University Hospital Halle (Saale), Halle (Saale), Germany.
  • Kraus FB; Central Laboratory, University Hospital Halle (Saale), Halle (Saale), Germany.
  • Dubourg V; Julius-Bernstein-Institute of Physiology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Zernecke A; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.
  • Schreier B; Julius-Bernstein-Institute of Physiology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Gekle M; Julius-Bernstein-Institute of Physiology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Benndorf RA; Department of Clinical Pharmacy and Pharmacotherapy, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. Electronic address: ralf.benndorf@pharmazie.uni-halle.de.
Free Radic Biol Med ; 185: 36-45, 2022 05 20.
Article em En | MEDLINE | ID: mdl-35470061
ABSTRACT
The F2-isoprostane 8-iso-PGF2α (also known as 15-F2t-isoprostane, iPF2α-III, 8-epi PGF2α, 15(S)-8-iso-PGF2α, or 8-Isoprostane), a thromboxane A2 receptor (TP) agonist, stable biomarker of oxidative stress, and risk marker of cardiovascular disease, has been proposed to aggravate atherogenesis in genetic mouse models of atherosclerotic vascular disease. Moreover, the TP plays an eminent role in the pathophysiology of endothelial dysfunction, atherogenesis, and cardiovascular disease. Yet it is unknown, how the TP expressed by vascular cells affects atherogenesis or 8-iso-PGF2α-related effects in mouse models of atherosclerosis. We studied Ldlr-deficient vascular endothelial-specific (EC) and vascular smooth muscle cell (VSMC)-specific TP knockout mice (TPECKO/Ldlr KO; TPVSMCKO/Ldlr KO) and corresponding wild-type littermates (TPWT/Ldlr KO). The mice were fed a Western-type diet for eight weeks and received either 8-iso-PGF2α or vehicle infusions via osmotic pumps. Subsequently, arterial blood pressure, atherosclerotic lesion formation, and lipid profiles were analyzed. We found that VSMC-, but not EC-specific TP deletion, attenuated atherogenesis without affecting blood pressure or plasma lipid profiles of the mice. In contrast to a previous report, 8-iso-PGF2α tended to reduce atherogenesis in TPWT/Ldlr KO and TPEC KO/Ldlr KO mice, again without significantly affecting blood pressure or lipid profiles of these mice. However, no further reduction in atherogenesis was observed in 8-iso-PGF2α-treated TPVSMC KO/Ldlr KO mice. Our work suggests that the TP expressed in VSMC but not the TP expressed in EC is involved in atherosclerotic lesion formation in Ldlr-deficient mice. Furthermore, we report an inhibitory effect of 8-iso-PGF2α on atherogenesis in this experimental atherosclerosis model, which paradoxically appears to be related to the presence of the TP in VSMC.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Free Radic Biol Med Assunto da revista: BIOQUIMICA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Free Radic Biol Med Assunto da revista: BIOQUIMICA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha